• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Oncology
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
    • Drug Development
    • Small Molecule Research & Development
    • Oncology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Heidi Overton
Biotech

Trump taps White House aide as next FDA commissioner

Overton served as a White House fellow during Trump’s first term, and pivoted to the America First Policy Institute after he lost reelection.
Darren Incorvaia Aug 19, 2026 10:17am
Building Resilience for the Future of Biopharma Innovation

Building Resilience for the Future of Biopharma Innovation

Brought to you by WuXi AppTec
brain in a petri dish

Human brain organoids model development for 5 years

Aug 19, 2026 11:00am
A ballpoint pen rests on top of a stack of documents ready for signing

Tolerance inks $260M deal for thymus-targeting fusion protein

Aug 19, 2026 10:00am
Moderna booth at AACR 2026

Merck-Moderna cancer vax slows recurrence in ph. 3 trial

Aug 19, 2026 6:45am
Merck  Co

Merck and Sarah Cannon team up for oncology trial efficiency

Aug 18, 2026 4:00pm
More News

Kolon TissueGene shrinks workforce after pivotal trial miss

Aug 18, 2026 4:00pm

Fierce Biotech Layoff Tracker 2026: Kolon, Sanofi & more

Aug 18, 2026 9:40am

BioMarin inks $275M Alesta buyout to challenge AstraZeneca

Aug 18, 2026 9:15am

Fierce Biotech Fundraising Tracker '26: Abcuro, InduPro & more

Aug 18, 2026 8:50am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings